Jim Cramer's Stop Trading! Pain Pill
Merck's
(MRK) - Get Merck & Company Inc. Report
plan to undercut competitors on price when Zocor loses its patent protection is "an attack on the generics, and it can succeed," Jim Cramer said on
CNBC'S
"Stop Trading!" segment Wednesday.
Teva
(TEVA) - Get Teva Pharmaceutical Industries Limited American Depositary Shares Report
was down 10% Wednesday on the news. Cramer mentioned
Barr Labs
( BRL) as the kind of generic producer that is also vulnerable to such attacks.
"This could cut margins to shreds" among generics, Cramer said. "I don't want any part of it."
As for the broad rally in stocks Wednesday, Cramer credited
Morgan Stanley
(MS) - Get Morgan Stanley Report
and
FedEx
TheStreet Recommends
(FDX) - Get FedEx Corporation Report
, which both reported strong earnings. The two companies "touch every aspect of business."
On the other hand, investors should be paying more attention to
Best Buy
(BBY) - Get Best Buy Co. Inc. Report
, which earlier raised its dividend and expanded a stock buyback. "Stop yawning, start buying," Cramer advised.
Another company receiving praise was
Darden
(DRI) - Get Darden Restaurants Inc. Report
, whose casual dining restaurants aren't proving vulnerable to high gasoline prices. "I find it interesting that it costs more t to drive to Olive Garden than it does to eat at Olive Garden," Cramer said.
At the time of publication, Cramer had no positions in the stocks mentioned.
Jim Cramer is a director and co-founder of TheStreet.com. He contributes daily market commentary for TheStreet.com's sites and serves as an adviser to the company's CEO. Outside contributing columnists for TheStreet.com and RealMoney.com, including Cramer, may, from time to time, write about stocks in which they have a position. In such cases, appropriate disclosure is made. To see his personal portfolio and find out what trades Cramer will make before he makes them, sign up for
Action Alerts PLUS. Listen to Cramer's RealMoney Radio show on your computer; just click
here. Watch Cramer on "Mad Money" at 6 p.m. ET weeknights on CNBC. Click
here to order Cramer's latest book, "Real Money: Sane Investing in an Insane World," click
here to get his second book, "You Got Screwed!" and click
here to order Cramer's autobiography, "Confessions of a Street Addict." While he cannot provide personalized investment advice or recommendations, he invites you to send comments on his column by
clicking here.
TheStreet.com has a revenue-sharing relationship with Traders' Library under which it receives a portion of the revenue from Traders' Library purchases by customers directed there from TheStreet.com.
